Hope to launch Covovax vaccine by September, says Serum Institute CEO

The vaccine has been tested against African and UK variants of coronavirus and has an overall efficacy of 89 per cent, Poonawalla says

Hope to launch Covovax vaccine by September and the trials have begun in India, said Serum Institute chief Adar Poonawalla on Saturday.

"Covovax trials finally began in India; the vaccine is made through a partnership with Novavax and Serum," Poonawalla said in a tweet.

The vaccine has been tested against African and UK variants of coronavirus and has an overall efficacy of 89 per cent, hope to launch by September 2021, he said.

In August 2020, US-based Novavax had announced a licence agreement with the Serum Institute for the development and commercialisation of its Covid-19 vaccine candidate, in low